US Stock MarketDetailed Quotes

MACK Merrimack Pharmaceuticals

Watchlist
  • 15.130
  • 0.0000.00%
Close May 17 16:00 ET
223.75MMarket Cap1.09P/E (TTM)

About Merrimack Pharmaceuticals Company

Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.

Company Profile

SymbolMACK
Company NameMerrimack Pharmaceuticals
Issue Price7.00
CEOMr. Gary L. Crocker
MarketNASDAQ
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Gary L. Crocker
  • Chairman of the Board, President, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • --
  • Ana Radeljevic
  • Independent Director
  • --
  • Noah G. Levy
  • Independent Director
  • --
  • Eric D. Andersen
  • Independent Director
  • --
  • Dr. Ulrik B. Nielsen
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data